InsidersTradesSigma
Follow the LDX share price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, LDX has published 3 reports. Market capitalisation: €110.5m. The latest transaction was reported on 18 June 2026 (Purchase). Among the most active insiders: DOUG WARD. All data is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€37,613
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LDX Strong Buy (bullish), based on 2 analysts. Average price target: A$0.30.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,565 of 29,052 companies
24.0
score / 100
Value17
Quality31
FCF yld-9.9%
Earn yld-7.6%
EV/EBITDA·
ROE-34%
Gross mgn63%
Net mgn-57%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 June 2026
About LDX
LDX is a company operating in the health and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance patient health.